Literature DB >> 9431919

Comparison of ATB staph, rapid ATB staph, Vitek, and E-test methods for detection of oxacillin heteroresistance in staphylococci possessing mecA.

N B Frebourg1, D Nouet, L Lemée, E Martin, J F Lemeland.   

Abstract

The performance characteristics of the E-test (AB Biodisk, Solna, Sweden), the ATB Staph, the Rapid ATB Staph, and the Vitek GPS-503 card (bioMérieux, La Balme Les Grottes, France) methods for the detection of oxacillin resistance in a collection of staphylococci with a high proportion of troublesome strains were evaluated. Sixty-four Staphylococcus aureus strains and 76 coagulase-negative staphylococcal strains were tested. All strains were mecA positive and were characterized by the oxacillin agar screen plate test; 75 (53.6%) were found to be heterogeneous by a large-inoculum oxacillin disk diffusion assay, and oxacillin MICs for 89 (63.6%) were < or = 32 microg/ml. Three (4.7%) S. aureus strains and 25 (32.9%) coagulase-negative strains were classified as susceptible by the E-test, as defined by the National Committee for Clinical Laboratory Standards (NCCLS) oxacillin breakpoint (MIC < or = 2 microg/ml). The ATB Staph method failed to detect oxacillin resistance in 7 (11%) S. aureus isolates and 32 (42.1%) coagulase-negative isolates. The MICs for all but six of these discrepant isolates were < or = 16 microg/ml. The Rapid ATB Staph method was tested against S. aureus strains only and yielded 15 (23.4%) false-susceptible results for strains for which the MICs were < or = 32 microg/ml. The Vitek system was the best-performing system, since it failed to detect oxacillin resistance in only 3 (4.7%) S. aureus strains and 15 (19.7%) coagulase-negative strains, the MICs for all of which were < or = 2 microg/ml. These data indicate that (i) the performance of the two ATB Staph systems can be limited when the prevalence of borderline-heteroresistant staphylococci is high and (ii) the unreliability of the E-test and the Vitek methods for detecting resistant coagulase-negative strains might be reduced by the potential revision of the oxacillin breakpoint currently recommended by the NCCLS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9431919      PMCID: PMC124806     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

1.  Correlation between regulation of mecA transcription and expression of methicillin resistance in staphylococci.

Authors:  C Ryffel; F H Kayser; B Berger-Bächi
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

2.  Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci.

Authors:  A Tomasz; S Nachman; H Leaf
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

3.  Comparison of a polymerase chain reaction assay and a conventional microbiologic method for detection of methicillin-resistant Staphylococcus aureus.

Authors:  Y Tokue; S Shoji; K Satoh; A Watanabe; M Motomiya
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

Review 4.  Methicillin-resistant staphylococci: detection methods and treatment of infections.

Authors:  C J Hackbarth; H F Chambers
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

5.  Multiple mechanisms of methicillin resistance and improved methods for detection in clinical isolates of Staphylococcus aureus.

Authors:  H de Lencastre; A M Sá Figueiredo; C Urban; J Rahal; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

6.  Rapid detection of the mecA gene in methicillin-resistant staphylococci by enzymatic detection of polymerase chain reaction products.

Authors:  K Ubukata; S Nakagami; A Nitta; A Yamane; S Kawakami; M Sugiura; M Konno
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

7.  Detection of methicillin-resistant staphylococci by using the polymerase chain reaction.

Authors:  S Unal; J Hoskins; J E Flokowitsch; C Y Wu; D A Preston; P L Skatrud
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

8.  Detection of methicillin resistance in staphylococci by using a DNA probe.

Authors:  G L Archer; E Pennell
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

9.  Evaluation of commercial and standard methodology for determination of oxacillin susceptibility in Staphylococcus aureus.

Authors:  M Skulnick; A E Simor; D Gregson; M Patel; G W Small; B Kreiswirth; D Hathoway; D E Low
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

10.  Comparison of conventional susceptibility tests with direct detection of penicillin-binding protein 2a in borderline oxacillin-resistant strains of Staphylococcus aureus.

Authors:  J L Gerberding; C Miick; H H Liu; H F Chambers
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191

View more
  27 in total

1.  Community acquisition of gentamicin-sensitive methicillin-resistant Staphylococcus aureus in southeast Queensland, Australia.

Authors:  G R Nimmo; J Schooneveldt; G O'Kane; B McCall; A Vickery
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

2.  Rapid PCR-based identification of methicillin-resistant Staphylococcus aureus from screening swabs.

Authors:  D Jonas; M Speck; F D Daschner; H Grundmann
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

3.  Coagulase-negative staphylococci: comparison of phenotypic and genotypic oxacillin susceptibility tests and evaluation of the agar screening test by using different concentrations of oxacillin.

Authors:  Rosana B R Ferreira; Natalia L P Iorio; Karoline L Malvar; Ana Paula F Nunes; Leila S Fonseca; Carla C R Bastos; Kátia R N Santos
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

4.  Identification of 2,600 clinical methicillin-resistant Staphylococcus aureus strains in The Netherlands yielded sporadic cases of strains negative for the species-specific Sa442 gene fragment.

Authors:  Frank Heilmann; Adri van der Zanden; Frans Reubsaet; Wim Wannet
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

Review 5.  Expert systems in clinical microbiology.

Authors:  Trevor Winstanley; Patrice Courvalin
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

Review 6.  Antimicrobial heteroresistance: an emerging field in need of clarity.

Authors:  Omar M El-Halfawy; Miguel A Valvano
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

7.  Misclassification of susceptible strains of Staphylococcus aureus as methicillin-resistant S. aureus By a rapid automated susceptibility testing system.

Authors:  J Ribeiro; F D Vieira; T King; J B D'Arezzo; J M Boyce
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

8.  Antistaphylococcal β-Lactams versus Vancomycin for Treatment of Infective Endocarditis Due to Methicillin-Susceptible Coagulase-Negative Staphylococci: a Prospective Cohort Study from the International Collaboration on Endocarditis.

Authors:  M Carugati; C A Petti; C Arnold; J M Miro; J M Pericàs; C Garcia de la Maria; Z Kanafani; E Durante-Mangoni; J Baddley; D Wray; J L Klein; F Delahaye; N Fernandez-Hidalgo; M M Hannan; D Murdoch; A Bayer; V H Chu
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

9.  Evaluation of an isothermal signal amplification method for rapid detection of methicillin-resistant Staphylococcus aureus from patient-screening swabs.

Authors:  Katrina Levi; Claire Bailey; Alexandra Bennett; Peter Marsh; Don L N Cardy; Kevin J Towner
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

10.  Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 system, and the MRSA-screen latex agglutination test.

Authors:  Annie Felten; Bernadette Grandry; Philippe Henri Lagrange; Isabelle Casin
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.